BRIEF-FDA grants orphan drug exclusivity to Spectrum Pharmaceutical's Evomela(tm)
April 20, 2016 at 07:26 AM EDT
* FDA grants orphan drug exclusivity to Evomela(tm) (melphalan) for injection, indicated for multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.